Twist Bioscience (TWST) Total Non-Current Liabilities (2018 - 2026)

Twist Bioscience has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $220.4 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 42.13% year-over-year to $220.4 million; the TTM figure through Mar 2026 stood at $220.4 million (up 42.13% YoY), while the FY2025 annual figure was $168.2 million, up 19.07% from the prior year.
• Total Non-Current Liabilities grew to $220.4 million in Q1 2026, from $181.2 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for TWST reached as high as $220.4 million in Q1 2026 and fell as low as $141.2 million in Q3 2024.
• The 5-year median for Total Non-Current Liabilities is $152.7 million (2023), against an average of $159.5 million.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 831.33% — and 2023, when it fell 13.01%.
• A 5-year view of Total Non-Current Liabilities shows it stood at $163.6 million in 2022, then dropped by 13.01% to $142.3 million in 2023, then climbed by 6.98% to $152.2 million in 2024, then increased by 19.06% to $181.2 million in 2025, then grew by 21.59% to $220.4 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $220.4 million, $181.2 million, and $168.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.